Human Growth Hormone Abuse in Male Weightlifters

被引:43
作者
Brennan, Brian P. [1 ,2 ]
Kanayama, Gen [1 ,2 ]
Hudson, James I. [1 ,2 ]
Pope, Harrison G., Jr. [1 ,2 ]
机构
[1] McLean Hosp, Biol Psychiat Lab, Belmont, MA 02478 USA
[2] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
关键词
ANDROGENIC STEROID USE; CARDIOVASCULAR-SYSTEM; I AXIS; USERS; ADOLESCENTS; DEPENDENCE; MORTALITY; NONUSERS; HEALTH; ISSUES;
D O I
10.1111/j.1521-0391.2010.00093.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
In a study of performance-enhancing substance use among 231 experienced young male weightlifters, we found that 27 (12%) reported illicit use of human growth hormone (HGH) or its bioactive derivative, insulin-like growth factor-1. All of these 27 men also reported use of anabolic-androgenic steroids (AAS) and 22 (81%) met criteria for current or past AAS dependence. Fifteen (56%) also reported current or past dependence on opioids, cocaine, and/or ecstasy. These findings suggest that among young male weightlifters, illicit HGH use has become a common form of substance abuse, frequently associated with both AAS dependence and classical substance dependence. (Am J Addict 2010;00:1-5).
引用
收藏
页码:9 / 13
页数:5
相关论文
共 40 条
[1]  
[Anonymous], 1998, STRUCTURED CLIN INTE
[2]  
[Anonymous], ANABOLICS
[3]   Does acromegaly enhance mortality? [J].
Ayuk, John ;
Sheppard, Michael C. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2008, 9 (01) :33-39
[4]   Long-Term Anabolic-Androgenic Steroid Use Is Associated With Left Ventricular Dysfunction [J].
Baggish, Aaron L. ;
Weiner, Rory B. ;
Kanayama, Gen ;
Hudson, James I. ;
Picard, Michael H. ;
Hutter, Adolph M., Jr. ;
Pope, Harrison G., Jr. .
CIRCULATION-HEART FAILURE, 2010, 3 (04) :472-U15
[5]   Steroid and prescription medicine abuse in the health and fitness community: A regional study [J].
Baker, J. S. ;
Graham, M. R. ;
Davies, B. .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2006, 17 (07) :479-484
[6]   Supraphysiological doses of GH induce rapid changes in cardiac morphology and function [J].
Cittadini, A ;
Berggren, A ;
Longobardi, S ;
Ehrnborg, C ;
Napoli, R ;
Rosén, T ;
Fazio, S ;
Caidahl, K ;
Bengtsson, BÅ ;
Saccà, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1654-1659
[7]   The heart: an end-organ of GH action [J].
Colao, A ;
Vitale, G ;
Pivonello, R ;
Ciccarelli, A ;
Di Somma, C ;
Lombardi, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 :S93-S101
[8]   The GH-IGF-I axis and the cardiovascular system: clinical implications [J].
Colao, Annamaria .
CLINICAL ENDOCRINOLOGY, 2008, 69 (03) :347-358
[9]  
DAHLBERG T, 2008, ASS PRESS 1029
[10]  
*EC21, EC21 GLOB B2B MARK